Article
Mutations define cross-talk between the N-terminal nucleotide-binding domain and transmembrane helix-2 of the yeast multidrug transporter Pdr5: possible conservation of a signaling interface for coupling ATP hydrolysis to drug transport.
The Journal of biological chemistry - 12 Dec 2008
Sauna Zuben E, Bohn Sherry Supernavage, Rutledge Robert, Dougherty Michael P, Cronin Susan, May Leopold, Xia Di, Ambudkar Suresh V, Golin John
Abstract excerpt
The yeast Pdr5 multidrug transporter is an important member of the ATP-binding cassette superfamily of proteins. We describe a novel mutation (S558Y) in transmembrane helix 2 of Pdr5 identified in a screen for suppressors that eliminated Pdr5-mediated cycloheximide hyper-resistance. Nucleotides as well as transport substrates bind to the mutant Pdr5 with an affinity comparable with that for wild-type Pdr5....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
